Safe plant Hsp90 adjuvants elicit an effective immune response against SARS-CoV2 derived RBD antigen
Víctor A. Ramos-Duarte, Alejandro Orlowski, Carolina Jaquenod de Giusti, Mariana Georgina Corigliano, Ariel Legarralde, Luisa F. Mendoza Morales, Agustín Atela, Manuel A. Sánchez, Valeria Analía Sander, Sergio Oscar Angel, Marina Clemente
This study compares two plant-derived Hsp90 adjuvants, showing that rNbHsp90.3 induces stronger neutralizing antibodies and different cytokine profiles than rAtHsp81.2 when used with SARS-CoV2 RBD antigen.
Vaccine · Apr 17, 2024Peer-reviewedMolecular Biology